In one study, administration of the IL-1β monoclonal antibody in mice deficient in IL1Ra (and therefore primed to the action of IL-1β) during AAA induction by angiotensin II infusion significantly reduced AAA size after 4 weeks [34]. The gene discussed is IL1R1; the disease is triple-A syndrome.